ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 163 filers reported holding ANI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,959,866 | +55.1% | 68,203 | +43.8% | 0.25% | +73.8% |
| Q2 2023 | $2,553,839 | +186.9% | 47,443 | +72.4% | 0.14% | +281.6% |
| Q2 2020 | $890,000 | -21.2% | 27,526 | -0.7% | 0.04% | -39.7% |
| Q1 2020 | $1,130,000 | -34.4% | 27,726 | -0.8% | 0.06% | +8.6% |
| Q4 2019 | $1,723,000 | -17.5% | 27,943 | -2.5% | 0.06% | -22.7% |
| Q3 2019 | $2,088,000 | -3.5% | 28,649 | +8.9% | 0.08% | +4.2% |
| Q2 2019 | $2,163,000 | +9.9% | 26,314 | -5.7% | 0.07% | +14.3% |
| Q1 2019 | $1,969,000 | +50.1% | 27,914 | -4.2% | 0.06% | +31.2% |
| Q4 2018 | $1,312,000 | -11.4% | 29,139 | +11.3% | 0.05% | -9.4% |
| Q3 2018 | $1,481,000 | -31.5% | 26,192 | -19.1% | 0.05% | -32.9% |
| Q2 2018 | $2,163,000 | +34.8% | 32,378 | -0.1% | 0.08% | +1.3% |
| Q1 2017 | $1,605,000 | -20.1% | 32,426 | -2.1% | 0.08% | -22.8% |
| Q4 2016 | $2,008,000 | -9.2% | 33,126 | -0.6% | 0.10% | -12.9% |
| Q3 2016 | $2,211,000 | – | 33,326 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |